These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 17050120)
1. Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. Terada T; Mizobata M; Kawakami S; Yabe Y; Yamashita F; Hashida M J Drug Target; 2006 Sep; 14(8):536-45. PubMed ID: 17050120 [TBL] [Abstract][Full Text] [Related]
2. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. Terada T; Mizobata M; Kawakami S; Yamashita F; Hashida M J Control Release; 2007 Jun; 119(3):262-70. PubMed ID: 17467100 [TBL] [Abstract][Full Text] [Related]
3. In vivo validation of biological responses of bFGF released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models. Falabella CA; Jiang H; Frame MD; Chen W J Biomater Sci Polym Ed; 2009; 20(7-8):903-22. PubMed ID: 19454159 [TBL] [Abstract][Full Text] [Related]
4. Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes. Lu J; Jeon E; Lee BS; Onyuksel H; Wang ZJ J Control Release; 2006 Feb; 110(3):505-13. PubMed ID: 16356575 [TBL] [Abstract][Full Text] [Related]
5. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599 [TBL] [Abstract][Full Text] [Related]
6. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells. Cai L; Qiu N; Li X; Luo K; Chen X; Yang L; He G; Wei Y; Chen L Int J Pharm; 2011 Apr; 408(1-2):173-82. PubMed ID: 21277964 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the protective effects of truncated bFGF and native bFGF against murine lung carcinoma. Luo Z; Peng X; Shi H; Gong C; Qian Z; Yang L Int J Mol Med; 2011 Jul; 28(1):3-8. PubMed ID: 21503566 [TBL] [Abstract][Full Text] [Related]
8. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844 [TBL] [Abstract][Full Text] [Related]
9. Basic Fibroblast Growth Factor Regulates Gene and Protein Expression Related to Proliferation, Differentiation, and Matrix Production of Human Dental Pulp Cells. Chang YC; Chang MC; Chen YJ; Liou JU; Chang HH; Huang WL; Liao WC; Chan CP; Jeng PY; Jeng JH J Endod; 2017 Jun; 43(6):936-942. PubMed ID: 28416318 [TBL] [Abstract][Full Text] [Related]
10. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751 [TBL] [Abstract][Full Text] [Related]
11. [Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy]. Ishida O; Maruyama K Nihon Rinsho; 1998 Mar; 56(3):657-62. PubMed ID: 9549352 [TBL] [Abstract][Full Text] [Related]
12. Barrier-penetrating liposome targeted delivery of basic fibroblast growth factor for spinal cord injury repair. Wu F; Wang P; Wei X; Yang Y; Al Mamun A; Zhang X; Zhu Y; Mo T; Zhang H; Jiang C; Hu J; Xiao J Mater Today Bio; 2023 Feb; 18():100546. PubMed ID: 36691606 [TBL] [Abstract][Full Text] [Related]
13. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment. Vila-Caballer M; Codolo G; Munari F; Malfanti A; Fassan M; Rugge M; Balasso A; de Bernard M; Salmaso S J Control Release; 2016 Sep; 238():31-42. PubMed ID: 27444816 [TBL] [Abstract][Full Text] [Related]
15. Peptides derived from specific interaction sites of the fibroblast growth factor 2-FGF receptor complexes induce receptor activation and signaling. Manfè V; Kochoyan A; Bock E; Berezin V J Neurochem; 2010 Jul; 114(1):74-86. PubMed ID: 20374425 [TBL] [Abstract][Full Text] [Related]
16. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo. Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757 [TBL] [Abstract][Full Text] [Related]
17. Prostate cells express two isoforms of fibroblast growth factor receptor 1 with different affinities for fibroblast growth factor-2. Roghani M; Moscatelli D Prostate; 2007 Feb; 67(2):115-24. PubMed ID: 17143873 [TBL] [Abstract][Full Text] [Related]
18. Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies. Jendryczko K; Rzeszotko J; Krzyscik MA; Kocyła A; Szymczyk J; Otlewski J; Szlachcic A Mol Pharm; 2022 May; 19(5):1422-1433. PubMed ID: 35389227 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system. Wu D; Song BW; Vinters HV; Pardridge WM J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825 [TBL] [Abstract][Full Text] [Related]
20. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]